Mangalam Drugs & Organics Limited (NSE:MANGALAM)
India · Delayed Price · Currency is INR 69.50
-0.69 (-0.98%)
Oct 20, 2025, 3:29 PM IST
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 1.11 billion as of October 20, 2025. Its market cap has decreased by -45.12% in one year.
Market Cap
1.11B
Enterprise Value
2.04B
Revenue
2.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
69.50
Market Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 1.11B, an increase of 416.87%. That is a compound annual growth rate of 8.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.11B | -39.01% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | 2.22B | 401.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.03T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.27T |
| Apollo Hospitals Enterprise | 1.14T |
| Mankind Pharma | 1.02T |
| Zydus Lifesciences | 993.81B |
| Fortis Healthcare | 819.05B |
| Alkem Laboratories | 667.35B |